Overview
Ipamorelin is a synthetic pentapeptide with growth hormone-releasing properties. It selectively stimulates growth hormone (GH) secretion without significantly affecting cortisol or prolactin levels, making it a preferred choice for those seeking the benefits of increased GH without the common side effects associated with other GH secretagogues. It's often used to promote muscle growth, improve sleep quality, and accelerate recovery.
Ipamorelin mimics the action of ghrelin, a hormone naturally produced in the stomach, by binding to the ghrelin receptor (also known as the growth hormone secretagogue receptor, or GHS-R1A). This binding stimulates the pituitary gland to release growth hormone. Unlike some other GH secretagogues, ipamorelin has a high selectivity for GH release, which minimizes the release of other hormones like cortisol, thereby reducing potential side effects.
Mechanism of Action
Ipamorelin works by binding to the ghrelin/GHS-R1A receptor in the pituitary gland. This receptor activation triggers a signaling cascade that ultimately leads to the release of growth hormone. The specificity of Ipamorelin is attributed to its unique structure, which allows it to selectively target the GH-releasing pathway while avoiding other hormonal pathways that could lead to adverse effects.
Unlike growth hormone-releasing hormone (GHRH), which also stimulates GH release, Ipamorelin does not deplete somatostatin, a hormone that inhibits GH release. This allows for a more pulsatile and physiological release of GH, mimicking the body's natural GH secretion patterns. The pulsatile release is beneficial as it helps maintain the sensitivity of GH receptors and prevents desensitization.
Key Benefits
- Promotes muscle growth and lean body mass
- Improves sleep quality and promotes deeper sleep
- Accelerates recovery from injuries and exercise
- Increases collagen production for healthier skin and joints
- May improve energy levels and overall well-being
Research & Indications
Research on Ipamorelin has primarily focused on its ability to stimulate growth hormone release and its potential therapeutic applications. Studies have shown that Ipamorelin can increase GH levels in both animals and humans, leading to improvements in body composition, bone density, and overall health. It has been investigated for potential use in treating growth hormone deficiencies, age-related muscle loss, and other conditions where increased GH levels may be beneficial.
The selective action of Ipamorelin on GH release, with minimal impact on cortisol and prolactin levels, makes it a potentially safer alternative to other GH secretagogues. This selectivity reduces the risk of side effects associated with elevated cortisol or prolactin, such as mood changes, water retention, and gynecomastia. However, further research is needed to fully understand the long-term effects and safety profile of Ipamorelin.
Dosing Protocols
Disclaimer: This information is not intended as medical advice. Consult with a qualified healthcare professional before using Ipamorelin or any other peptide.
Typical dosing protocols for Ipamorelin involve subcutaneous injections. Doses range from 200-300 mcg administered 1-3 times daily. Cycle lengths typically run for 8-16 weeks, followed by a break to maintain receptor sensitivity.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Muscle Growth/Recovery | 200-300mcg | 1-3x daily | SubQ |
Supplies Needed
For an 8-16 week protocol:
- Peptide Vials: 2-6 vials of 5mg each, or 1-3 vials of 10mg each
- Insulin Syringes (U-100): Approximately 100-200 syringes
- Bacteriostatic Water: 1-2 × 10mL bottles
- Alcohol Swabs: One for vial + one for injection site daily
Side Effects & Safety
Ipamorelin is generally well-tolerated, but potential side effects may include injection site reactions (redness, itching, or pain), headache, and lightheadedness. Some users have reported increased hunger or thirst. Because Ipamorelin stimulates growth hormone release, there is a theoretical risk of long-term effects associated with elevated GH levels, such as insulin resistance or carpal tunnel syndrome. However, these risks are considered low due to the pulsatile and physiological nature of GH release with Ipamorelin.
Storage & Handling
Ipamorelin should be stored in lyophilized (freeze-dried) form at -20°C (freezer) for long-term storage. Once reconstituted with bacteriostatic water, it should be stored at 2-8°C (refrigerator) and used within 30 days. Avoid freezing the reconstituted solution. Handle with care to prevent contamination.